Home/Investors/Schroders Capital

Schroders Capital

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

5

Top Stage

Phase 2

Investment Focus

Neuropsychiatry Major Depressive Disorder Lysosomal Storage Disorders Rare Metabolic Diseases Neurology

Portfolio Companies

Company	Stage	Valuation	Focus
Draig Therapeutics	Phase 2	—	Neuropsychiatry, Major Depressive Disorder
Azafaros	Phase 3	—	Lysosomal Storage Disorders, Rare Metabolic Diseases

Frequent Co-Investors

Forbion1 shared Sanofi Ventures1 shared SR One1 shared SV Health Investors1 shared Jeito Capital1 shared BioGeneration Ventures (BGV)1 shared Canaan Partners1 shared Access Biotechnology1 shared